Dulaglutide vs Ipilimumab

## Dulaglutide vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Dulaglutide** and **Ipilimumab**.

## Mechanism of Action

**Dulaglutide**: GLP-1 receptor agonist fused to Fc fragment; enhances glucose-dependent insulin secretion.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Dulaglutide — 5 days; Ipilimumab — 14.7 days.

## Chemical Properties

**Type**: Dulaglutide — Protein; Ipilimumab — Antibody.